$514 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | Buy | ILLUMINA INC | $48,247,614 | +73.0% | 207,472 | +50.4% | 9.39% | +46.0% |
| IQV | Buy | IQVIA HLDGS INC | $45,047,591 | +7.7% | 226,495 | +11.0% | 8.77% | -9.1% |
| NTRA | Sell | NATERA INC | $43,577,315 | +33.1% | 784,894 | -3.7% | 8.48% | +12.3% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $36,555,202 | +27.3% | 143,090 | +32.2% | 7.12% | +7.4% |
| SGEN | SEAGEN INC | $35,412,408 | +57.6% | 174,902 | 0.0% | 6.89% | +33.0% | |
| ICLR | Buy | ICON PLC | $33,298,681 | +39.3% | 155,900 | +26.6% | 6.48% | +17.5% |
| UTHR | UNITED THERAPEUTICS CORP DEL | $29,392,062 | -19.5% | 131,238 | 0.0% | 5.72% | -32.0% | |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $27,394,962 | -26.0% | 136,756 | -12.2% | 5.33% | -37.5% |
| DXCM | Buy | DEXCOM INC | $26,907,288 | +8.5% | 231,600 | +5.8% | 5.24% | -8.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $23,994,152 | +5.0% | 64,400 | +6.8% | 4.67% | -11.4% |
| INSP | INSPIRE MED SYS INC | $23,768,170 | -7.1% | 101,543 | 0.0% | 4.63% | -21.6% | |
| LNTH | New | LANTHEUS HLDGS INC | $23,513,088 | – | 284,800 | +100.0% | 4.58% | – |
| OM | Sell | OUTSET MED INC | $22,087,084 | -29.9% | 1,200,385 | -1.7% | 4.30% | -40.9% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $19,108,751 | – | 138,640 | +100.0% | 3.72% | – |
| TNDM | Sell | TANDEM DIABETES CARE INC | $17,280,570 | -34.9% | 425,525 | -27.9% | 3.36% | -45.1% |
| GH | Buy | GUARDANT HEALTH INC | $13,983,390 | +672.4% | 596,561 | +796.3% | 2.72% | +551.2% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $10,727,214 | +131.0% | 1,214,860 | +99.9% | 2.09% | +95.0% |
| New | PROCEPT BIOROBOTICS CORP | $8,071,791 | – | 284,218 | +100.0% | 1.57% | – | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $7,527,690 | -22.6% | 437,911 | 0.0% | 1.46% | -34.7% | |
| AGIO | AGIOS PHARMACEUTICALS INC | $6,147,461 | -18.2% | 267,630 | 0.0% | 1.20% | -31.0% | |
| CANO | Buy | CANO HEALTH INC | $3,904,720 | +1193.9% | 4,290,901 | +1847.9% | 0.76% | +985.7% |
| AMWL | AMERICAN WELL CORPcl a | $3,292,292 | -16.6% | 1,395,039 | 0.0% | 0.64% | -29.6% | |
| CMAX | CAREMAX INC | $1,908,396 | -26.8% | 714,755 | 0.0% | 0.37% | -38.2% | |
| OLK | OLINK HLDG ABsponsored ads | $901,200 | -11.2% | 40,000 | 0.0% | 0.18% | -25.2% | |
| BEAM | BEAM THERAPEUTICS INC | $884,918 | -21.7% | 28,900 | 0.0% | 0.17% | -34.1% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $499,845 | -28.1% | 23,500 | 0.0% | 0.10% | -39.4% | |
| LYEL | LYELL IMMUNOPHARMA INC | $236,000 | -32.0% | 100,000 | 0.0% | 0.05% | -42.5% | |
| ARVN | Exit | ARVINAS INC | $0 | – | -23,000 | -100.0% | -0.18% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -49,200 | -100.0% | -0.41% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -329,100 | -100.0% | -3.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.